Homeβ€ΊSearchβ€ΊTherapeutic Advances in Cardiovascular Disease

Therapeutic Advances in Cardiovascular Disease

SAGE Publications Ltd Β· United Kingdom Β· Est. 1964

ISSN1753-9455
SJR Q2βœ“ WOS ESCIβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
84
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† Scopus Q266
βœ“ Corroboration (3 more)+18
Total84
Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
9
weeks to publish Β· journal-reported
Fast Β· vs ~15 wk median
Q2
SJR Rank
Top 50% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (ESCI) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.862
H-Indexi
49
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
0.895
Total Worksi
532
Total Citationsi
10,975
2yr Mean Citednessi
3.68
Open Impact Factor alternative
Retractions
1
Source: Retraction Watch

Aims & Scope

Subject areas: Cardiac & Cardiovascular System; Cardiology and Cardiovascular Medicine; Pharmacology (medical).

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1964
FrequencyBimonthly
StatusActive (last: 2026)
Total Publications532
Publisher OrgSAGE Publishing
OA Since2018
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
Review Time~9 weeks
Acceptance Rateβ€”
OA LicenseCC BY, CC BY-NC
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes

Think.Check.Submit Compliance

9/12 Β· 75%
βœ…
Do you know the journal / publisher?
SAGE Publications Ltd
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1753-9455
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
βœ…
Peer review process documented?
Single-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
21
780
2019
19
279
2020
10
181
2021
13
128
2022
17
152
2023
28
208
2024
14
19
2025
15
4
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Cardiology and Cardiovascular MedicineQ2
Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

Cardiac & Cardiovascular System

Scopus Categories

Pharmacology (medical)Cardiology and Cardiovascular Medicine

Research Topics (OpenAlex)

Blood Pressure and Hypertension StudiesHeart Failure Treatment and ManagementAtrial Fibrillation Management and OutcomesCoronary Interventions and DiagnosticsRenin-Angiotensin System StudiesAcute Myocardial Infarction ResearchLipoproteins and Cardiovascular HealthCardiovascular Function and Risk FactorsHormonal Regulation and HypertensionCardiac electrophysiology and arrhythmias

Frequently asked questions about Therapeutic Advances in Cardiovascular Disease

Is Therapeutic Advances in Cardiovascular Disease a predatory journal?

PubScope has no integrity flags on record for Therapeutic Advances in Cardiovascular Disease: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 84/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Therapeutic Advances in Cardiovascular Disease?

Therapeutic Advances in Cardiovascular Disease is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 3.68.

Is Therapeutic Advances in Cardiovascular Disease indexed in Scopus and Web of Science?

Therapeutic Advances in Cardiovascular Disease is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Therapeutic Advances in Cardiovascular Disease?

Subject areas: Cardiac & Cardiovascular System; Cardiology and Cardiovascular Medicine; Pharmacology (medical).

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref